While reported revenue appears lower than previous years, this reflects exclusion of divested EMS rev- historically a significant contributor
To note here: current figures are in-flght contracts - underscoring current baseline without consideration of considerable advanced stage contracts in pipeline (circa ~$500m)
Valuation and reprice will be dynamic, with future awards the key catalyst for upside potential
I am curious however, to see what the opex re-baselining would look like in Q2, agnostic to EMS. Until then, let's see how market reacts to this
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$2.90 |
Change
0.000(0.00%) |
Mkt cap ! $559.5M | |||
| Open | High | Low | Value | Volume |
| $2.93 | $2.93 | $2.83 | $3.626M | 1.259M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 300 | $2.88 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.90 | 10499 | 3 |
View Market Depth
| Last trade - 16.10pm 11/07/2025 (20 minute delay) ? |
| EOS (ASX) Chart |